These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 10701820

  • 1. Angiotensin II upregulates transforming growth factor-beta type I receptor on rat vascular smooth muscle cells.
    Fukuda N, Hu WY, Kubo A, Kishioka H, Satoh C, Soma M, Izumi Y, Kanmatsuse K.
    Am J Hypertens; 2000 Feb; 13(2):191-8. PubMed ID: 10701820
    [Abstract] [Full Text] [Related]

  • 2. Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II.
    Fukuda N, Hu WY, Kubo A, Endoh M, Kishioka H, Satoh C, Soma M, Izumi Y, Kanmatsuse K.
    Hypertension; 1998 Feb; 31(2):672-7. PubMed ID: 9461239
    [Abstract] [Full Text] [Related]

  • 3. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats.
    Satoh C, Fukuda N, Hu WY, Nakayama M, Kishioka H, Kanmatsuse K.
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):108-18. PubMed ID: 11152368
    [Abstract] [Full Text] [Related]

  • 4. Effect of AT2 receptor on expression of AT1 and TGF-beta receptors in VSMCs from SHR.
    Su JZ, Fukuda N, Jin XQ, Lai YM, Suzuki R, Tahira Y, Takagi H, Ikeda Y, Kanmatsuse K, Miyazaki H.
    Hypertension; 2002 Dec; 40(6):853-8. PubMed ID: 12468569
    [Abstract] [Full Text] [Related]

  • 5. Differential regulation of transforming growth factor receptors by angiotensin II and transforming growth factor-beta1 in vascular smooth muscle.
    Siegert A, Ritz E, Orth S, Wagner J.
    J Mol Med (Berl); 1999 May; 77(5):437-45. PubMed ID: 10426193
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of protein tyrosine kinases attenuates increases in expression of transforming growth factor-beta isoforms and their receptors following arterial injury.
    Ward MR, Agrotis A, Kanellakis P, Dilley R, Jennings G, Bobik A.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2461-70. PubMed ID: 9409216
    [Abstract] [Full Text] [Related]

  • 7. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Hu WY, Teng J, Chikara S, Nakayama M, Kishioka H, Kanmatsuse K.
    Atherosclerosis; 2002 Aug; 163(2):229-39. PubMed ID: 12052469
    [Abstract] [Full Text] [Related]

  • 8. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
    Gibbons GH, Pratt RE, Dzau VJ.
    J Clin Invest; 1992 Aug; 90(2):456-61. PubMed ID: 1644917
    [Abstract] [Full Text] [Related]

  • 9. Characteristics and expression of transforming growth factor-beta receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Kubo A, Izumi Y, Soma M, Kanmatsuse K.
    J Hypertens; 1995 Aug; 13(8):831-7. PubMed ID: 8557960
    [Abstract] [Full Text] [Related]

  • 10. Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells.
    Hamaguchi A, Kim S, Izumi Y, Zhan Y, Yamanaka S, Iwao H.
    Hypertension; 1999 Jul; 34(1):126-31. PubMed ID: 10406835
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR.
    Kubo A, Fukuda N, Teng J, Satoh C, Nakayama M, Kishioka H, Kanmatsuse K.
    Am J Hypertens; 2000 Oct; 13(10):1117-24. PubMed ID: 11041167
    [Abstract] [Full Text] [Related]

  • 12. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, Kubo A, Kanmatsuse K.
    J Hypertens; 1999 Aug; 17(8):1099-107. PubMed ID: 10466465
    [Abstract] [Full Text] [Related]

  • 13. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins.
    Morrell NW, Yang X, Upton PD, Jourdan KB, Morgan N, Sheares KK, Trembath RC.
    Circulation; 2001 Aug 14; 104(7):790-5. PubMed ID: 11502704
    [Abstract] [Full Text] [Related]

  • 14. Low dose of eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-beta.
    Nakayama M, Fukuda N, Watanabe Y, Soma M, Hu WY, Kishioka H, Satoh C, Kubo A, Kanmatsuse K.
    J Hypertens; 1999 Oct 14; 17(10):1421-30. PubMed ID: 10526902
    [Abstract] [Full Text] [Related]

  • 15. Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells.
    Wolf G, Schroeder R, Ziyadeh FN, Stahl RA.
    Kidney Int; 2004 Nov 14; 66(5):1849-58. PubMed ID: 15496155
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor beta 1 modulates angiotensin II-induced calcium influx in vascular smooth muscle.
    Zhu Z, Tepel M, Neusser M, Zidek W.
    Eur J Clin Invest; 1995 May 14; 25(5):317-21. PubMed ID: 7628518
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor.
    Teng J, Fukuda N, Suzuki R, Takagi H, Ikeda Y, Tahira Y, Kanmatsuse K.
    J Cardiovasc Pharmacol; 2002 Feb 14; 39(2):161-71. PubMed ID: 11791001
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.
    Waiser J, Dell K, Böhler T, Dogu E, Gaedeke J, Budde K, Neumayer HH.
    Nephrol Dial Transplant; 2002 Sep 14; 17(9):1568-77. PubMed ID: 12198207
    [Abstract] [Full Text] [Related]

  • 19. Regulation of peroxisome proliferator-activated receptor-γ by angiotensin II via transforming growth factor-β1-activated p38 mitogen-activated protein kinase in aortic smooth muscle cells.
    Subramanian V, Golledge J, Heywood EB, Bruemmer D, Daugherty A.
    Arterioscler Thromb Vasc Biol; 2012 Feb 14; 32(2):397-405. PubMed ID: 22095985
    [Abstract] [Full Text] [Related]

  • 20. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL, Yaswen LR, Tarnuzzer RW, Moldawer LL, Bland KI, Copeland EM, Schultz GS.
    Ann Surg; 1995 Jun 14; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.